Study of association between cinacalcet use and missed in-center hemodialysis treatment rate

Trial Profile

Study of association between cinacalcet use and missed in-center hemodialysis treatment rate

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2016

At a glance

  • Drugs Cinacalcet (Primary)
  • Indications Secondary hyperparathyroidism
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jul 2016 New trial record
    • 27 Jun 2016 Primary endpoint (Stabilized IP of censoring or crossover weighted) has been met, according to results published in the Pharmacoepidemiology and Drug Safety.
    • 27 Jun 2016 Primary endpoint (Stabilized IP of censoring weighted)has been met, according to results published in the Pharmacoepidemiology and Drug Safety
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top